Español
Questions About Cancer? 1-800-4-CANCER
  • Email

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-19 of 19 for your search:
Cancer Type/Condition:  Brain tumor, child: Medulloblastoma
Stage/Subtype:  untreated childhood medulloblastoma
Trial Type:  Treatment
Trial Status:  Active
Start Over
        Show
1.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 3 to 21
Sponsor: NCI, Other
Protocol IDs: ACNS0332, NCI-2009-00336, COG-ACNS0332, CDR0000511991, R01CA114567, U10CA098543, U10CA180886, NCT00392327

2.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 2 to 18
Sponsor: Pharmaceutical / Industry
Protocol IDs: DFI12860, 2010-019340-40, MOZ15609, NCT01288573

3.

Phase: Phase II
Type: Supportive care, Treatment
Status: Active
Age: 3 to 30 at initial diagnosis
Sponsor: Other
Protocol IDs: CDR0000069075, CHP-693, CHP-IRB-2001-12-2301, NCI-V01-1680, NCT00031590

4.

Phase: Phase II
Type: Treatment
Status: Active
Age: 10 and under
Sponsor: Other
Protocol IDs: PNET HR, NCT00180791

5.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: Any age
Sponsor: Other
Protocol IDs: 05-122, MSKCC-05122, NCT00445965

6.

Phase: Phase II
Type: Treatment
Status: Active
Age: Children
Sponsor: Other
Protocol IDs: 2005-12-009, NCT00798811

7.

Phase: Phase II
Type: Treatment
Status: Active
Age: 5 to 19
Sponsor: Other
Protocol IDs: PNET HR+ 5, CSET 1329, NCT00936156

8.

Phase: Phase II
Type: Treatment
Status: Active
Age: 6 months to 17 years
Sponsor: Other
Protocol IDs: CDR0000066490, BC-BT-10, NCT00003458

9.

Phase: Phase II
Type: Natural history/Epidemiology, Treatment
Status: Active
Age: 1 to 25
Sponsor: NCI, Other
Protocol IDs: 10-206, NCT01288235

10.

Phase: Phase II
Type: Treatment
Status: Active
Age: 3 to 25
Sponsor: Other
Protocol IDs: 06-1151, NCT01542736

11.

Phase: Phase II
Type: Treatment
Status: Active
Age: 6 to 18
Sponsor: Other
Protocol IDs: HSJD-GLIOMAS-IC, NCT01574092

12.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 47 months old or younger
Sponsor: NCI, Other
Protocol IDs: ACNS1221, NCI-2013-02379, COG-ACNS1221, U10CA098543, U10CA180886, NCT02017964

13.

Phase: Phase I
Type: Treatment
Status: Active
Age: 3 to 22
Sponsor: Pharmaceutical / Industry
Protocol IDs: 07-098, NCT00634231

14.

Phase: Phase I
Type: Treatment
Status: Approved-not yet active
Age: 21 and under
Sponsor: Other
Protocol IDs: 2013-0765, NCT02271711

15.

Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: Under 3 at diagnosis
Sponsor: NCI, Other
Protocol IDs: SJYC07, R01CA154619, SJCRH-SJYC07, NCT00602667

16.

Phase: No phase specified
Type: Natural history/Epidemiology, Treatment
Status: Active
Age: 2 to 25
Sponsor: Other
Protocol IDs: 2005P001629, NCT01115777

17.

Phase: No phase specified
Type: Treatment
Status: Active
Age: 70 and under
Sponsor: Other
Protocol IDs: 2011OC057, MT2011-09C, NCT01505569

18.

Phase: No phase specified
Type: Diagnostic, Treatment
Status: Active
Age: 21 and under
Sponsor: Other
Protocol IDs: 201303069, NCT01999270

19.

Phase: No phase specified
Type: Treatment
Status: Approved-not yet active
Age: 3 to 18
Sponsor: Other
Protocol IDs: J1403, NA_00091840, NCT02212574
New Search